Industry Research Reports

Home > Reports > Chemical & Material > Global Pharmaceutical Grade Dydrogesterone Market Research Report 2026

Global Pharmaceutical Grade Dydrogesterone Market Research Report 2026

Industry: Chemical & Material

Published Date: 2026-02-02

Pages: 119 Pages

Report ld: 5859465

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Pharmaceutical Grade Dydrogesterone Market Size(US$)

CAGR 2026-2032

4.2%

Market Size,2032

USD 260

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 204 million

Market Forecast in 2032(Value)

US$ 260 million

CAGR

4.2%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Pharmaceutical Grade Dydrogesterone market was valued at US$ 196 million in 2025 and is anticipated to reach US$ 260 million by 2032, at a CAGR of 4.2% from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pharmaceutical Grade Dydrogesterone competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Pharmaceutical-grade dydrogesterone is an oral synthetic progestogen drug with a chemical name of 9β,10α-pregnane-4,6-diene-3,20-dione. Its molecular structure is highly similar to natural progesterone but has stronger biological activity. The drug simulates the effects of endogenous progesterone and specifically binds to the progesterone receptor (PR), exerting pharmacological effects such as regulating the secretory phase transformation of the endometrium, inhibiting estrogen overstimulation, and stabilizing the myometrium. It is mainly used clinically to treat gynecological diseases such as dysmenorrhea, endometriosis, secondary amenorrhea, dysfunctional uterine bleeding, premenstrual syndrome, and threatened abortion caused by insufficient endogenous progesterone. Its core advantages lie in its high bioavailability (up to 28%), potent progestin activity, and the characteristics of not inhibiting ovulation, making it one of the core drugs in the field of obstetrics and gynecology for regulating hormone balance, protecting pregnancy, and treating endometrial-related diseases.

As a key hormone drug for the treatment of diseases related to endogenous progesterone deficiency, pharmaceutical-grade dydrogesterone currently presents a market pattern dominated by original research drugs and accelerated breakthroughs in generic drugs. At the same time, technological innovation and expansion of clinical applications promote the sustainable development of the industry. The original research drug Dafutong has long occupied 99.86% of the domestic market share, but since the first generic drug of Auriate Pharmaceuticals was launched in 2023, companies such as Hangzhou Heze Kunyuan and Sichuan Kelun Pharmaceuticals have been approved one after another, breaking the global generic drug gap of more than 60 years and forming a "original research 1 + domestic 3" competition pattern. On the technical level, dydrogesterone has a high selectivity for progesterone receptors due to its unique "reversed" stereostructure, a bioavailability of 28%, and no estrogen, androgen and corticosteroid effects, fewer side effects, and is recommended by authoritative guidelines at home and abroad for endometriosis, threatened abortion, assisted reproductive technology and other scenarios. Market dynamics show that domestic sales will exceed 2 billion yuan in 2023, with an annual compound growth rate of more than 13%. With the breakthrough of generic drug technical barriers and the expectation of centralized procurement, the accessibility of drugs will be significantly improved. In the future, the industry will focus on formulation innovation (such as sustained release, nanotechnology), production process optimization (green pharmaceuticals, biocatalysis) and personalized treatment (genomics, biomarkers). At the same time, intelligent drug management and remote monitoring technologies will further improve patient compliance and promote the in-depth application of dydrogesterone in gynecology and reproductive fields.

This report delivers a comprehensive overview of the global Pharmaceutical Grade Dydrogesterone market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Grade Dydrogesterone. The Pharmaceutical Grade Dydrogesterone market size, estimates, and forecasts are provided in terms of output/shipments (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Pharmaceutical Grade Dydrogesterone market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Pharmaceutical Grade Dydrogesterone manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Abbott Laboratories
Yangzhou Aurisco Pharmaceutical
Hangzhou Hezekunyuan Pharmaceutical
Sichuan Kelun Pharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Dydrogesterone Tablets (Single Progestin Drug)
Estradiol Dydrogesterone Tablets (Combined Preparation)

Segment by Application

Gynecological Disease Treatment
Reproductive Medicine
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Provides a detailed analysis of the competitive landscape for Pharmaceutical Grade Dydrogesterone manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.

Chapter 3: Examines Pharmaceutical Grade Dydrogesterone production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.

Chapter 4: Analyzes Pharmaceutical Grade Dydrogesterone consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.

Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.

Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.

Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.

Chapter 8: Reviews the industry value chain, including upstream and downstream segments.

Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.

Chapter 10: Summarizes the key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Pharmaceutical Grade Dydrogesterone Market Overview

1.1 Product Definition

1.2 Pharmaceutical Grade Dydrogesterone by Type

1.2.1 Global Pharmaceutical Grade Dydrogesterone Market Value Growth Rate Analysis by Type: 2025 vs 2032

1.2.2 Dydrogesterone Tablets (Single Progestin Drug)

1.2.3 Estradiol Dydrogesterone Tablets (Combined Preparation)

1.3 Pharmaceutical Grade Dydrogesterone by Application

1.3.1 Global Pharmaceutical Grade Dydrogesterone Market Value Growth Rate Analysis by Application: 2025 vs 2032

1.3.2 Gynecological Disease Treatment

1.3.3 Reproductive Medicine

1.3.4 Others

1.4 Global Market Growth Prospects

1.4.1 Global Pharmaceutical Grade Dydrogesterone Production Value Estimates and Forecasts (2021–2032)

1.4.2 Global Pharmaceutical Grade Dydrogesterone Production Capacity Estimates and Forecasts (2021–2032)

1.4.3 Global Pharmaceutical Grade Dydrogesterone Production Estimates and Forecasts (2021–2032)

1.4.4 Global Pharmaceutical Grade Dydrogesterone Market Average Price Estimates and Forecasts (2021–2032)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Pharmaceutical Grade Dydrogesterone Production Market Share by Manufacturers (2021–2026)

2.2 Global Pharmaceutical Grade Dydrogesterone Production Value Market Share by Manufacturers (2021–2026)

2.3 Global Key Players of Pharmaceutical Grade Dydrogesterone, Industry Ranking, 2024 vs 2025

2.4 Global Pharmaceutical Grade Dydrogesterone Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.5 Global Pharmaceutical Grade Dydrogesterone Average Price by Manufacturers (2021–2026)

2.6 Global Key Manufacturers of Pharmaceutical Grade Dydrogesterone, Manufacturing Footprints and Headquarters

2.7 Global Key Manufacturers of Pharmaceutical Grade Dydrogesterone, Product Offerings and Applications

2.8 Global Key Manufacturers of Pharmaceutical Grade Dydrogesterone, Date of Entry into the Industry

2.9 Pharmaceutical Grade Dydrogesterone Market Competitive Situation and Trends

2.9.1 Pharmaceutical Grade Dydrogesterone Market Concentration Rate

2.9.2 Top 5 and Top 10 Global Pharmaceutical Grade Dydrogesterone Players Market Share by Revenue

2.10 Mergers & Acquisitions and Expansion

3 Pharmaceutical Grade Dydrogesterone Production by Region

3.1 Global Pharmaceutical Grade Dydrogesterone Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.2 Global Pharmaceutical Grade Dydrogesterone Production Value by Region (2021–2032)

3.2.1 Global Pharmaceutical Grade Dydrogesterone Production Value by Region (2021–2026)

3.2.2 Global Forecasted Production Value of Pharmaceutical Grade Dydrogesterone by Region (2027–2032)

3.3 Global Pharmaceutical Grade Dydrogesterone Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.4 Global Pharmaceutical Grade Dydrogesterone Production Volume by Region (2021–2032)

3.4.1 Global Pharmaceutical Grade Dydrogesterone Production by Region (2021–2026)

3.4.2 Global Forecasted Production of Pharmaceutical Grade Dydrogesterone by Region (2027–2032)

3.5 Global Pharmaceutical Grade Dydrogesterone Market Price Analysis by Region (2021–2026)

3.6 Global Pharmaceutical Grade Dydrogesterone Production, Value, and Year-over-Year Growth

3.6.1 North America Pharmaceutical Grade Dydrogesterone Production Value Estimates and Forecasts (2021–2032)

3.6.2 Europe Pharmaceutical Grade Dydrogesterone Production Value Estimates and Forecasts (2021–2032)

3.6.3 China Pharmaceutical Grade Dydrogesterone Production Value Estimates and Forecasts (2021–2032)

3.6.4 Japan Pharmaceutical Grade Dydrogesterone Production Value Estimates and Forecasts (2021–2032)

4 Pharmaceutical Grade Dydrogesterone Consumption by Region

4.1 Global Pharmaceutical Grade Dydrogesterone Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

4.2 Global Pharmaceutical Grade Dydrogesterone Consumption by Region (2021–2032)

4.2.1 Global Pharmaceutical Grade Dydrogesterone Consumption by Region (2021–2026)

4.2.2 Global Pharmaceutical Grade Dydrogesterone Forecasted Consumption by Region (2027–2032)

4.3 North America

4.3.1 North America Pharmaceutical Grade Dydrogesterone Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.3.2 North America Pharmaceutical Grade Dydrogesterone Consumption by Country (2021–2032)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Pharmaceutical Grade Dydrogesterone Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.4.2 Europe Pharmaceutical Grade Dydrogesterone Consumption by Country (2021–2032)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Pharmaceutical Grade Dydrogesterone Consumption Growth Rate by Region: 2021 vs 2025 vs 2032

4.5.2 Asia Pacific Pharmaceutical Grade Dydrogesterone Consumption by Region (2021–2032)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Pharmaceutical Grade Dydrogesterone Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.6.2 Latin America, Middle East & Africa Pharmaceutical Grade Dydrogesterone Consumption by Country (2021–2032)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Pharmaceutical Grade Dydrogesterone Production by Type (2021–2032)

5.1.1 Global Pharmaceutical Grade Dydrogesterone Production by Type (2021–2026)

5.1.2 Global Pharmaceutical Grade Dydrogesterone Production by Type (2027–2032)

5.1.3 Global Pharmaceutical Grade Dydrogesterone Production Market Share by Type (2021–2032)

5.2 Global Pharmaceutical Grade Dydrogesterone Production Value by Type (2021–2032)

5.2.1 Global Pharmaceutical Grade Dydrogesterone Production Value by Type (2021–2026)

5.2.2 Global Pharmaceutical Grade Dydrogesterone Production Value by Type (2027–2032)

5.2.3 Global Pharmaceutical Grade Dydrogesterone Production Value Market Share by Type (2021–2032)

5.3 Global Pharmaceutical Grade Dydrogesterone Price by Type (2021–2032)

6 Segment by Application

6.1 Global Pharmaceutical Grade Dydrogesterone Production by Application (2021–2032)

6.1.1 Global Pharmaceutical Grade Dydrogesterone Production by Application (2021–2026)

6.1.2 Global Pharmaceutical Grade Dydrogesterone Production by Application (2027–2032)

6.1.3 Global Pharmaceutical Grade Dydrogesterone Production Market Share by Application (2021–2032)

6.2 Global Pharmaceutical Grade Dydrogesterone Production Value by Application (2021–2032)

6.2.1 Global Pharmaceutical Grade Dydrogesterone Production Value by Application (2021–2026)

6.2.2 Global Pharmaceutical Grade Dydrogesterone Production Value by Application (2027–2032)

6.2.3 Global Pharmaceutical Grade Dydrogesterone Production Value Market Share by Application (2021–2032)

6.3 Global Pharmaceutical Grade Dydrogesterone Price by Application (2021–2032)

7 Key Companies Profiled

7.1 Abbott Laboratories

7.1.1 Abbott Laboratories Pharmaceutical Grade Dydrogesterone Company Information

7.1.2 Abbott Laboratories Pharmaceutical Grade Dydrogesterone Product Portfolio

7.1.3 Abbott Laboratories Pharmaceutical Grade Dydrogesterone Production, Value, Price, and Gross Margin (2021–2026)

7.1.4 Abbott Laboratories Main Business and Markets Served

7.1.5 Abbott Laboratories Recent Developments/Updates

7.2 Yangzhou Aurisco Pharmaceutical

7.2.1 Yangzhou Aurisco Pharmaceutical Pharmaceutical Grade Dydrogesterone Company Information

7.2.2 Yangzhou Aurisco Pharmaceutical Pharmaceutical Grade Dydrogesterone Product Portfolio

7.2.3 Yangzhou Aurisco Pharmaceutical Pharmaceutical Grade Dydrogesterone Production, Value, Price, and Gross Margin (2021–2026)

7.2.4 Yangzhou Aurisco Pharmaceutical Main Business and Markets Served

7.2.5 Yangzhou Aurisco Pharmaceutical Recent Developments/Updates

7.3 Hangzhou Hezekunyuan Pharmaceutical

7.3.1 Hangzhou Hezekunyuan Pharmaceutical Pharmaceutical Grade Dydrogesterone Company Information

7.3.2 Hangzhou Hezekunyuan Pharmaceutical Pharmaceutical Grade Dydrogesterone Product Portfolio

7.3.3 Hangzhou Hezekunyuan Pharmaceutical Pharmaceutical Grade Dydrogesterone Production, Value, Price, and Gross Margin (2021–2026)

7.3.4 Hangzhou Hezekunyuan Pharmaceutical Main Business and Markets Served

7.3.5 Hangzhou Hezekunyuan Pharmaceutical Recent Developments/Updates

7.4 Sichuan Kelun Pharmaceutical

7.4.1 Sichuan Kelun Pharmaceutical Pharmaceutical Grade Dydrogesterone Company Information

7.4.2 Sichuan Kelun Pharmaceutical Pharmaceutical Grade Dydrogesterone Product Portfolio

7.4.3 Sichuan Kelun Pharmaceutical Pharmaceutical Grade Dydrogesterone Production, Value, Price, and Gross Margin (2021–2026)

7.4.4 Sichuan Kelun Pharmaceutical Main Business and Markets Served

7.4.5 Sichuan Kelun Pharmaceutical Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Pharmaceutical Grade Dydrogesterone Industry Chain Analysis

8.2 Pharmaceutical Grade Dydrogesterone Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Pharmaceutical Grade Dydrogesterone Production Modes and Processes

8.4 Pharmaceutical Grade Dydrogesterone Sales and Marketing

8.4.1 Pharmaceutical Grade Dydrogesterone Sales Channels

8.4.2 Pharmaceutical Grade Dydrogesterone Distributors

8.5 Pharmaceutical Grade Dydrogesterone Customer Analysis

9 Pharmaceutical Grade Dydrogesterone Market Dynamics

9.1 Pharmaceutical Grade Dydrogesterone Industry Trends

9.2 Pharmaceutical Grade Dydrogesterone Market Drivers

9.3 Pharmaceutical Grade Dydrogesterone Market Challenges

9.4 Pharmaceutical Grade Dydrogesterone Market Restraints

9.5 Impact of U.S. Tariffs

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Pharmaceutical Grade Dydrogesterone Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Pharmaceutical Grade Dydrogesterone Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Pharmaceutical Grade Dydrogesterone Production Capacity (kg) by Manufacturers in 2025

Table 4. Global Pharmaceutical Grade Dydrogesterone Production by Manufacturers (kg), 2021–2026

Table 5. Global Pharmaceutical Grade Dydrogesterone Production Market Share by Manufacturers (2021–2026)

Table 6. Global Pharmaceutical Grade Dydrogesterone Production Value by Manufacturers (US$ Million), 2021–2026

Table 7. Global Pharmaceutical Grade Dydrogesterone Production Value Share by Manufacturers (2021–2026)

Table 8. Global Key Players of Pharmaceutical Grade Dydrogesterone, Industry Ranking, 2024 vs 2025

Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharmaceutical Grade Dydrogesterone Production Value, 2025

Table 10. Global Market Pharmaceutical Grade Dydrogesterone Average Price by Manufacturers (US$/g), 2021–2026

Table 11. Global Key Manufacturers of Pharmaceutical Grade Dydrogesterone, Manufacturing Footprints and Headquarters

Table 12. Global Key Manufacturers of Pharmaceutical Grade Dydrogesterone, Product Offerings and Applications

Table 13. Global Key Manufacturers of Pharmaceutical Grade Dydrogesterone, Date of Entry into the Industry

Table 14. Global Pharmaceutical Grade Dydrogesterone Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Pharmaceutical Grade Dydrogesterone Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Pharmaceutical Grade Dydrogesterone Production Value (US$ Million) by Region (2021–2026)

Table 18. Global Pharmaceutical Grade Dydrogesterone Production Value Market Share by Region (2021–2026)

Table 19. Global Pharmaceutical Grade Dydrogesterone Production Value (US$ Million) Forecast by Region (2027–2032)

Table 20. Global Pharmaceutical Grade Dydrogesterone Production Value Market Share Forecast by Region (2027–2032)

Table 21. Global Pharmaceutical Grade Dydrogesterone Production Comparison by Region: 2021 vs 2025 vs 2032 (kg)

Table 22. Global Pharmaceutical Grade Dydrogesterone Production (kg) by Region (2021–2026)

Table 23. Global Pharmaceutical Grade Dydrogesterone Production Market Share by Region (2021–2026)

Table 24. Global Pharmaceutical Grade Dydrogesterone Production (kg) Forecast by Region (2027–2032)

Table 25. Global Pharmaceutical Grade Dydrogesterone Production Market Share Forecast by Region (2027–2032)

Table 26. Global Pharmaceutical Grade Dydrogesterone Market Average Price (US$/g) by Region (2021–2026)

Table 27. Global Pharmaceutical Grade Dydrogesterone Market Average Price (US$/g) by Region (2027–2032)

Table 28. Global Pharmaceutical Grade Dydrogesterone Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (kg)

Table 29. Global Pharmaceutical Grade Dydrogesterone Consumption by Region (kg), 2021–2026

Table 30. Global Pharmaceutical Grade Dydrogesterone Consumption Market Share by Region (2021–2026)

Table 31. Global Pharmaceutical Grade Dydrogesterone Forecasted Consumption by Region (kg), 2027–2032

Table 32. Global Pharmaceutical Grade Dydrogesterone Forecasted Consumption Market Share by Region (2027–2032)

Table 33. North America Pharmaceutical Grade Dydrogesterone Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)

Table 34. North America Pharmaceutical Grade Dydrogesterone Consumption by Country (kg), 2021–2026

Table 35. North America Pharmaceutical Grade Dydrogesterone Consumption by Country (kg), 2027–2032

Table 36. Europe Pharmaceutical Grade Dydrogesterone Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)

Table 37. Europe Pharmaceutical Grade Dydrogesterone Consumption by Country (kg), 2021–2026

Table 38. Europe Pharmaceutical Grade Dydrogesterone Consumption by Country (kg), 2027–2032

Table 39. Asia Pacific Pharmaceutical Grade Dydrogesterone Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (kg)

Table 40. Asia Pacific Pharmaceutical Grade Dydrogesterone Consumption by Region (kg), 2021–2026

Table 41. Asia Pacific Pharmaceutical Grade Dydrogesterone Consumption by Region (kg), 2027–2032

Table 42. Latin America, Middle East & Africa Pharmaceutical Grade Dydrogesterone Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)

Table 43. Latin America, Middle East & Africa Pharmaceutical Grade Dydrogesterone Consumption by Country (kg), 2021–2026

Table 44. Latin America, Middle East & Africa Pharmaceutical Grade Dydrogesterone Consumption by Country (kg), 2027–2032

Table 45. Global Pharmaceutical Grade Dydrogesterone Production (kg) by Type (2021–2026)

Table 46. Global Pharmaceutical Grade Dydrogesterone Production (kg) by Type (2027–2032)

Table 47. Global Pharmaceutical Grade Dydrogesterone Production Market Share by Type (2021–2026)

Table 48. Global Pharmaceutical Grade Dydrogesterone Production Market Share by Type (2027–2032)

Table 49. Global Pharmaceutical Grade Dydrogesterone Production Value (US$ Million) by Type (2021–2026)

Table 50. Global Pharmaceutical Grade Dydrogesterone Production Value (US$ Million) by Type (2027–2032)

Table 51. Global Pharmaceutical Grade Dydrogesterone Production Value Market Share by Type (2021–2026)

Table 52. Global Pharmaceutical Grade Dydrogesterone Production Value Market Share by Type (2027–2032)

Table 53. Global Pharmaceutical Grade Dydrogesterone Price (US$/g) by Type (2021–2026)

Table 54. Global Pharmaceutical Grade Dydrogesterone Price (US$/g) by Type (2027–2032)

Table 55. Global Pharmaceutical Grade Dydrogesterone Production (kg) by Application (2021–2026)

Table 56. Global Pharmaceutical Grade Dydrogesterone Production (kg) by Application (2027–2032)

Table 57. Global Pharmaceutical Grade Dydrogesterone Production Market Share by Application (2021–2026)

Table 58. Global Pharmaceutical Grade Dydrogesterone Production Market Share by Application (2027–2032)

Table 59. Global Pharmaceutical Grade Dydrogesterone Production Value (US$ Million) by Application (2021–2026)

Table 60. Global Pharmaceutical Grade Dydrogesterone Production Value (US$ Million) by Application (2027–2032)

Table 61. Global Pharmaceutical Grade Dydrogesterone Production Value Market Share by Application (2021–2026)

Table 62. Global Pharmaceutical Grade Dydrogesterone Production Value Market Share by Application (2027–2032)

Table 63. Global Pharmaceutical Grade Dydrogesterone Price (US$/g) by Application (2021–2026)

Table 64. Global Pharmaceutical Grade Dydrogesterone Price (US$/g) by Application (2027–2032)

Table 65. Abbott Laboratories Pharmaceutical Grade Dydrogesterone Company Information

Table 66. Abbott Laboratories Pharmaceutical Grade Dydrogesterone Specification and Application

Table 67. Abbott Laboratories Pharmaceutical Grade Dydrogesterone Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 68. Abbott Laboratories Main Business and Markets Served

Table 69. Abbott Laboratories Recent Developments/Updates

Table 70. Yangzhou Aurisco Pharmaceutical Pharmaceutical Grade Dydrogesterone Company Information

Table 71. Yangzhou Aurisco Pharmaceutical Pharmaceutical Grade Dydrogesterone Specification and Application

Table 72. Yangzhou Aurisco Pharmaceutical Pharmaceutical Grade Dydrogesterone Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 73. Yangzhou Aurisco Pharmaceutical Main Business and Markets Served

Table 74. Yangzhou Aurisco Pharmaceutical Recent Developments/Updates

Table 75. Hangzhou Hezekunyuan Pharmaceutical Pharmaceutical Grade Dydrogesterone Company Information

Table 76. Hangzhou Hezekunyuan Pharmaceutical Pharmaceutical Grade Dydrogesterone Specification and Application

Table 77. Hangzhou Hezekunyuan Pharmaceutical Pharmaceutical Grade Dydrogesterone Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 78. Hangzhou Hezekunyuan Pharmaceutical Main Business and Markets Served

Table 79. Hangzhou Hezekunyuan Pharmaceutical Recent Developments/Updates

Table 80. Sichuan Kelun Pharmaceutical Pharmaceutical Grade Dydrogesterone Company Information

Table 81. Sichuan Kelun Pharmaceutical Pharmaceutical Grade Dydrogesterone Specification and Application

Table 82. Sichuan Kelun Pharmaceutical Pharmaceutical Grade Dydrogesterone Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)

Table 83. Sichuan Kelun Pharmaceutical Main Business and Markets Served

Table 84. Sichuan Kelun Pharmaceutical Recent Developments/Updates

Table 85. Key Raw Materials Lists

Table 86. Raw Materials Key Suppliers Lists

Table 87. Pharmaceutical Grade Dydrogesterone Distributors List

Table 88. Pharmaceutical Grade Dydrogesterone Customers List

Table 89. Pharmaceutical Grade Dydrogesterone Market Trends

Table 90. Pharmaceutical Grade Dydrogesterone Market Drivers

Table 91. Pharmaceutical Grade Dydrogesterone Market Challenges

Table 92. Pharmaceutical Grade Dydrogesterone Market Restraints

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pharmaceutical Grade Dydrogesterone

Figure 2. Global Pharmaceutical Grade Dydrogesterone Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Pharmaceutical Grade Dydrogesterone Market Share by Type: 2025 vs 2032

Figure 4. Dydrogesterone Tablets (Single Progestin Drug) Product Picture

Figure 5. Estradiol Dydrogesterone Tablets (Combined Preparation) Product Picture

Figure 6. Global Pharmaceutical Grade Dydrogesterone Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Pharmaceutical Grade Dydrogesterone Market Share by Application: 2025 vs 2032

Figure 8. Gynecological Disease Treatment

Figure 9. Reproductive Medicine

Figure 10. Others

Figure 11. Global Pharmaceutical Grade Dydrogesterone Production Value (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Pharmaceutical Grade Dydrogesterone Production Value (US$ Million), 2021–2032

Figure 13. Global Pharmaceutical Grade Dydrogesterone Production Capacity (kg), 2021–2032

Figure 14. Global Pharmaceutical Grade Dydrogesterone Production (kg), 2021–2032

Figure 15. Global Pharmaceutical Grade Dydrogesterone Average Price (US$/g), 2021–2032

Figure 16. Pharmaceutical Grade Dydrogesterone Report Years Considered

Figure 17. Pharmaceutical Grade Dydrogesterone Production Share by Manufacturers in 2025

Figure 18. Global Pharmaceutical Grade Dydrogesterone Production Value Share by Manufacturers (2025)

Figure 19. Pharmaceutical Grade Dydrogesterone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 20. Top 5 and Top 10 Global Players: Market Share by Pharmaceutical Grade Dydrogesterone Revenue in 2025

Figure 21. Global Pharmaceutical Grade Dydrogesterone Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Figure 22. Global Pharmaceutical Grade Dydrogesterone Production Value Market Share by Region: 2021 vs 2025 vs 2032

Figure 23. Global Pharmaceutical Grade Dydrogesterone Production Comparison by Region: 2021 vs 2025 vs 2032 (kg)

Figure 24. Global Pharmaceutical Grade Dydrogesterone Production Market Share by Region: 2021 vs 2025 vs 2032

Figure 25. North America Pharmaceutical Grade Dydrogesterone Production Value (US$ Million) Growth Rate (2021–2032)

Figure 26. Europe Pharmaceutical Grade Dydrogesterone Production Value (US$ Million) Growth Rate (2021–2032)

Figure 27. China Pharmaceutical Grade Dydrogesterone Production Value (US$ Million) Growth Rate (2021–2032)

Figure 28. Japan Pharmaceutical Grade Dydrogesterone Production Value (US$ Million) Growth Rate (2021–2032)

Figure 29. Global Pharmaceutical Grade Dydrogesterone Consumption by Region: 2021 vs 2025 vs 2032 (kg)

Figure 30. Global Pharmaceutical Grade Dydrogesterone Consumption Market Share by Region: 2021 vs 2025 vs 2032

Figure 31. North America Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 32. North America Pharmaceutical Grade Dydrogesterone Consumption Market Share by Country (2021–2032)

Figure 33. U.S. Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 34. Canada Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 35. Europe Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 36. Europe Pharmaceutical Grade Dydrogesterone Consumption Market Share by Country (2021–2032)

Figure 37. Germany Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 38. France Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 39. U.K. Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 40. Italy Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 41. Russia Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 42. Asia Pacific Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 43. Asia Pacific Pharmaceutical Grade Dydrogesterone Consumption Market Share by Region (2021–2032)

Figure 44. China Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 45. Japan Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 46. South Korea Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 47. China Taiwan Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 48. Southeast Asia Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 49. India Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 50. Latin America, Middle East & Africa Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 51. Latin America, Middle East & Africa Pharmaceutical Grade Dydrogesterone Consumption Market Share by Country (2021–2032)

Figure 52. Mexico Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 53. Brazil Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 54. Turkey Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 55. GCC Countries Pharmaceutical Grade Dydrogesterone Consumption and Growth Rate (kg), 2021–2032

Figure 56. Global Production Market Share of Pharmaceutical Grade Dydrogesterone by Type (2021–2032)

Figure 57. Global Production Value Market Share of Pharmaceutical Grade Dydrogesterone by Type (2021–2032)

Figure 58. Global Pharmaceutical Grade Dydrogesterone Price (US$/g) by Type (2021–2032)

Figure 59. Global Production Market Share of Pharmaceutical Grade Dydrogesterone by Application (2021–2032)

Figure 60. Global Production Value Market Share of Pharmaceutical Grade Dydrogesterone by Application (2021–2032)

Figure 61. Global Pharmaceutical Grade Dydrogesterone Price (US$/g) by Application (2021–2032)

Figure 62. Pharmaceutical Grade Dydrogesterone Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Pharmaceutical Grade Dydrogesterone market size from 2026 to 2032? zhanKai

The annual compound growth rate of the global Pharmaceutical Grade Dydrogesterone market is 4.2% 2026 to 2032.

What was the global market size of Pharmaceutical Grade Dydrogesterone in 2032? shouQi

Which companies rank high in the global Pharmaceutical Grade Dydrogesterone market? shouQi

What was the global market size of Pharmaceutical Grade Dydrogesterone in 2026? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Pharmaceutical Grade Dydrogesterone- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Grade Dydrogesterone was estimated to be worth US$ 196 million in 2025 and is projected to reach US$ 260 million, growing at a CAGR of 4.2% from 2026 to 2032.
Published Date: 2026-02-02
Pages: 87
USD 3950.00
(Single User License)
Global Pharmaceutical Grade Dydrogesterone Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Grade Dydrogesterone market is projected to grow from US$ 189 million in 2024 to US$ 251 million by 2031, at a CAGR of 4.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 113
USD 4900.00
(Single User License)
Pharmaceutical Grade Dydrogesterone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Grade Dydrogesterone was estimated to be worth US$ 189 million in 2024 and is forecast to a readjusted size of US$ 251 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Published Date: 2025-06-04
Pages: 85
USD 3950.00
(Single User License)
Global Pharmaceutical Grade Dydrogesterone Market Insights, Forecast to 2031
The global Pharmaceutical Grade Dydrogesterone market is projected to grow from US$ 196 million in 2025 to US$ 251 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period.
Published Date: 2025-06-04
Pages: 111
USD 4900.00
(Single User License)
Global Pharmaceutical Grade Dydrogesterone Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Grade Dydrogesterone market size was US$ 189 million in 2024 and is forecast to a readjusted size of US$ 251 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Published Date: 2025-06-04
Pages: 66
USD 4250.00
(Single User License)
Global Pharmaceutical Grade Dydrogesterone Market Research Report 2025
The global market for Pharmaceutical Grade Dydrogesterone was valued at US$ 189 million in the year 2024 and is projected to reach a revised size of US$ 251 million by 2031, growing at a CAGR of 4.2% during the forecast period.
Published Date: 2025-06-04
Pages: 78
USD 2900.00
(Single User License)
Pharmaceutical Grade Dydrogesterone- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Grade Dydrogesterone was estimated to be worth US$ 189 million in 2024 and is forecast to a readjusted size of US$ 247 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 87
USD 3950.00
(Single User License)
Global Pharmaceutical Grade Dydrogesterone Market Insights, Forecast to 2030
The global Pharmaceutical Grade Dydrogesterone market is projected to grow from US$ 182 million in 2024 to US$ 230.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.0% during the forecast period.
Published Date: 2024-04-13
Pages: 76
USD 4900.00
(Single User License)
Global Pharmaceutical Grade Dydrogesterone Market Research Report 2024
The global Pharmaceutical Grade Dydrogesterone market was valued at US$ 175 million in 2023 and is anticipated to reach US$ 230.3 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
Published Date: 2024-02-21
Pages: 76
USD 2900.00
(Single User License)
Pharmaceutical Grade Dydrogesterone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Pharmaceutical Grade Dydrogesterone was estimated to be worth US$ 175 million in 2023 and is forecast to a readjusted size of US$ 230.3 million by 2030 with a CAGR of 4.0% during the forecast period 2024-2030
Published Date: 2024-02-19
Pages: 88
USD 3950.00
(Single User License)

Pharmaceutical Grade Dydrogesterone- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Grade Dydrogesterone was estimated to be worth US$ 196 million in 2025 and is projected to reach US$ 260 million, growing at a CAGR of 4.2% from 2026 to 2032.
Published: 2026-02-02
Pages: 87
USD 3950.00 (Single User License)
Global Pharmaceutical Grade Dydrogesterone Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Grade Dydrogesterone market is projected to grow from US$ 189 million in 2024 to US$ 251 million by 2031, at a CAGR of 4.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 113
USD 4900.00 (Single User License)
Pharmaceutical Grade Dydrogesterone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Grade Dydrogesterone was estimated to be worth US$ 189 million in 2024 and is forecast to a readjusted size of US$ 251 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Published: 2025-06-04
Pages: 85
USD 3950.00 (Single User License)
Global Pharmaceutical Grade Dydrogesterone Market Insights, Forecast to 2031
The global Pharmaceutical Grade Dydrogesterone market is projected to grow from US$ 196 million in 2025 to US$ 251 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period.
Published: 2025-06-04
Pages: 111
USD 4900.00 (Single User License)
Global Pharmaceutical Grade Dydrogesterone Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Grade Dydrogesterone market size was US$ 189 million in 2024 and is forecast to a readjusted size of US$ 251 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.
Published: 2025-06-04
Pages: 66
USD 4250.00 (Single User License)
Global Pharmaceutical Grade Dydrogesterone Market Research Report 2025
The global market for Pharmaceutical Grade Dydrogesterone was valued at US$ 189 million in the year 2024 and is projected to reach a revised size of US$ 251 million by 2031, growing at a CAGR of 4.2% during the forecast period.
Published: 2025-06-04
Pages: 78
USD 2900.00 (Single User License)
Pharmaceutical Grade Dydrogesterone- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Grade Dydrogesterone was estimated to be worth US$ 189 million in 2024 and is forecast to a readjusted size of US$ 247 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 87
USD 3950.00 (Single User License)
Global Pharmaceutical Grade Dydrogesterone Market Insights, Forecast to 2030
The global Pharmaceutical Grade Dydrogesterone market is projected to grow from US$ 182 million in 2024 to US$ 230.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.0% during the forecast period.
Published: 2024-04-13
Pages: 76
USD 4900.00 (Single User License)
Global Pharmaceutical Grade Dydrogesterone Market Research Report 2024
The global Pharmaceutical Grade Dydrogesterone market was valued at US$ 175 million in 2023 and is anticipated to reach US$ 230.3 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
Published: 2024-02-21
Pages: 76
USD 2900.00 (Single User License)
Pharmaceutical Grade Dydrogesterone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Pharmaceutical Grade Dydrogesterone was estimated to be worth US$ 175 million in 2023 and is forecast to a readjusted size of US$ 230.3 million by 2030 with a CAGR of 4.0% during the forecast period 2024-2030
Published: 2024-02-19
Pages: 88
USD 3950.00 (Single User License)